Found: 84
Select item for more details and to access through your institution.
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00945-0
- By:
- Publication type:
- Article
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. e37, doi. 10.1111/bjh.18753
- By:
- Publication type:
- Article
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. e23, doi. 10.1111/bjh.17393
- By:
- Publication type:
- Article
Gene expression profiling predicts relapse‐free and overall survival in newly diagnosed myeloma patients treated with novel therapies.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 4, p. e115, doi. 10.1111/bjh.17344
- By:
- Publication type:
- Article
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 781, doi. 10.1111/bjh.14954
- By:
- Publication type:
- Article
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 561, doi. 10.1111/bjh.14731
- By:
- Publication type:
- Article
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 4, p. 567, doi. 10.1111/bjh.14596
- By:
- Publication type:
- Article
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 3, p. 444, doi. 10.1111/bjh.13977
- By:
- Publication type:
- Article
Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 836, doi. 10.1002/ajh.27254
- By:
- Publication type:
- Article
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 562, doi. 10.1002/ajh.27233
- By:
- Publication type:
- Article
Safety and efficacy of a new high‐dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high‐risk myeloma: Matched‐pair comparisons with concurrent control cohorts.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 245, doi. 10.1002/ajh.27168
- By:
- Publication type:
- Article
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E35, doi. 10.1002/ajh.26789
- By:
- Publication type:
- Article
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 140, doi. 10.1002/ajh.26596
- By:
- Publication type:
- Article
Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule-Dose Regimes.
- Published in:
- Biometrics, 2013, v. 69, n. 3, p. 673, doi. 10.1111/biom.12065
- By:
- Publication type:
- Article
Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 12, p. 1011, doi. 10.1093/ajhp/zxac055
- By:
- Publication type:
- Article
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5690, doi. 10.3390/cancers15235690
- By:
- Publication type:
- Article
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5888, doi. 10.3390/cancers13235888
- By:
- Publication type:
- Article
POEMS syndrome: A multisystem clonal disorder.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 14, doi. 10.1111/ejh.13514
- By:
- Publication type:
- Article
Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta‐analysis.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 5, p. 420, doi. 10.1111/ejh.13374
- By:
- Publication type:
- Article
Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S261, doi. 10.3816/CLM.2009.s.021
- By:
- Publication type:
- Article
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11712-6
- By:
- Publication type:
- Article
A randomized study comparing chemotherapy followed by G-CS F alone or in combination with GM-CS F for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.
- Published in:
- Journal of Blood Medicine, 2010, v. 1, p. 49, doi. 10.2147/jbm.s9846
- By:
- Publication type:
- Article
Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The Development of a Myeloablative, Reduced-Toxicity, Conditioning Regimen for Cord Blood Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. e1, doi. 10.1016/j.clml.2013.08.006
- By:
- Publication type:
- Article
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 485, doi. 10.1016/j.clml.2013.02.023
- By:
- Publication type:
- Article
Survival Disparities Between African American and Caucasian Patients With Multiple Myeloma Are Blunted in the Era of Novel Therapeutics and Autologous Stem Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E31, doi. 10.3816/CLML.2010.n.041
- By:
- Publication type:
- Article
Steroid-Refractory Acute GVHD: Predictors and Outcomes.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Steroid-Refractory Acute GVHD: Predictors and Outcomes.
- Published in:
- Advances in Hematology, 2011, v. 2011, p. 1, doi. 10.1155/2011/601953
- By:
- Publication type:
- Article
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 6, p. 532, doi. 10.1111/ejh.12970
- By:
- Publication type:
- Article
Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 3, p. 263, doi. 10.1111/ejh.12826
- By:
- Publication type:
- Article
Modified CVAD and modified CBAD compared to high-dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 4, p. 388, doi. 10.1111/ejh.12843
- By:
- Publication type:
- Article
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 4, p. 342, doi. 10.1111/ejh.12736
- By:
- Publication type:
- Article
In-Hospital Complications of Autologous Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 5, p. 1096, doi. 10.1002/cncr.23281
- By:
- Publication type:
- Article
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 5, p. 1084, doi. 10.1002/cncr.21700
- By:
- Publication type:
- Article
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12).
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 2, p. 308, doi. 10.1038/sj.cgt.7700105
- By:
- Publication type:
- Article
P-197: Central nervous system Multiple Myeloma (CNS-MM), presentation and outcomes in an Era of anti-CD38 and pomalidomide inclusive therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S146, doi. 10.1016/S2152-2650(21)02324-7
- By:
- Publication type:
- Article
CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S446, doi. 10.1016/S2152-2650(21)01992-3
- By:
- Publication type:
- Article
Poster: CT-046: Post-Transplant Cyclophosphamide in HLA-Matched and Haploidentical Transplant Recipients Receiving a Myeloablative Fractionated Busulfan Conditioning Regimen: Results of a Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S258, doi. 10.1016/S2152-2650(21)01627-X
- By:
- Publication type:
- Article
Impact of cytogenetics versus FISH detected t(11;14) in newly diagnosed multiple myeloma patients with upfront transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e218, doi. 10.1016/j.clml.2019.09.363
- By:
- Publication type:
- Article
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.250
- By:
- Publication type:
- Article
A Case Control Study of Syngeneic Transplantation Versus Autologous Transplantation for Multiple Myeloma: Two Decades of Experience at MD Anderson.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e8, doi. 10.1016/j.clml.2017.03.014
- By:
- Publication type:
- Article
Post Autologous Transplant (autoHCT)Therapies in High Risk MM. Subgroup analysis of Phase III BMTCTN 0702 STAMINA: autoHCT Followed by Lenalidomide Maintenance(Len)(AM) vs auto HCT and Len and Bortezomib (BZ) and Dexamethasone Consolidation Len Maintenance(ACM) vs Tandem autoHCT Len Maintenance
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e5, doi. 10.1016/j.clml.2017.03.009
- By:
- Publication type:
- Article
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Financial toxicity in hematological malignancies: a systematic review.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00671-z
- By:
- Publication type:
- Article
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00624-6
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 126, doi. 10.1007/s11899-017-0374-1
- By:
- Publication type:
- Article